Costing Issues in the Production of Biopharmaceuticals

BioPharm International

Volumn 17, Issue 2, 2004, Pages 46-55

  Rathore, Anurag S ^a   Latham, Peter ^b   Levine, Howard ^c   Curling, John ^d   Kaltenbrunner, Oliver ^e  

^a AMGEN INC   (United States)

^b BioPharm Services Inc

^c BioProcess Technology Consultants Inc   (United States)

^d John Curling Consulting AB   (Sweden)

^e Plant Engineering

Author keywords

[No Author keywords available]

Indexed keywords

COMMERCIAL PHENOMENA; COMPUTER MODEL; COST BENEFIT ANALYSIS; COST CONTROL; DRUG COST; DRUG INDUSTRY; DRUG MANUFACTURE; ECONOMIC ASPECT; MANAGEMENT; MANPOWER PLANNING; MATHEMATICAL MODEL; MONTE CARLO METHOD; PLANNING; PROFIT; REVIEW;

EID: 1242316343     PISSN: 1542166X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (11)

1. Agres T. Better future for pharma/biotech? Drug Discovery & Development 2002, Dec 15.
2. Curling J, Baines D. The cost of chromatography. IBC:Production and Economics of Biopharmaceuticals; 2000 Nov 13-15;La Jolla, CA.
3. Rosenberg, M. Development cost and process economics for biologicals derived from recombinant, natural products fermentation, and mammalian cell culture. IBC: Production and Economics of Biopharmaceuticals; 2000 Nov 13-15;La Jolla, CA.
4. Sadana A, Beelaram, AM. Efficiency and economics of bioseparation: some case studies, Bioseparation 1994;(4):221.
5. WarnerTN, Nochumson S. Rethinking the economics of chromatography. BioPharm International 2003;16(1).
6. Novais JL, Titchener-Hookner NJ, Hoare M. Economic comparison between conventional and disposables-based technology for the production of biopharmaceuticals, Biotech. Bioeng. 2001;(75):143.
7. Mullen J. The position of biopharmaceuticals in the future. IBC: Production and Economics of Biopharmaceuticals; 2000 Nov 13-15; La Jolla, CA.
8. Mun J. Applied risk analysis: moving beyond uncertainty. Hoboken (NJ): Wiley Finance, 2003.
9. Myers J. Economic considerations in the development of downstream steps for large scale commercial biopharmaceutical processes. IBC: Production and Economics of Biopharmaceuticals;2000 Nov 13-15;La Jolla, CA.
10. Karri S, Davies E, Titchener-Hooker NJ, Washbrook J. Biopharmaceutical process development: part III. J. BioPharm Europe; Sept 2001:76-82.
11. Pisano GP. The development factory. Boston (MA): Harvard Business School Press; 1997.